On a return trip from the California appeals court, a malpractice and breach of fiduciary duty suit by Simpson's former client has survived the firm's motion to dismiss on statute of limitations grounds.

Looks like we're going to have to revise our take on early trends in subprime fraud litigation. Two crucial rulings that came at the end of last week--denying motions to dismiss class actions against onetime mortgage giants Countrywide and New Century--show that the plaintiffs bar isn't giving up and going away. In fact, if we're going to keep our subprime-litigation-as-a-baseball-game metaphor going, you could say that the plaintiffs in Countrywide and New Century right now have the bases loaded with no outs.

We imagine that the partners at Manatt, Phelps & Phillips never, ever again want to hear, see, or think of anything having to do with Princess Diana.

Abbott didn't just lose a pair of patent infringement cases at trial in 2008. It got killed. In one, a federal judge ruled the company's patent invalid because of Abbott's inequitable conduct. In the other, a federal jury deemed Abbott's patent invalid. And on Monday, the appeals court validated both results.

The Supreme Court on Monday searched for middle ground in the ongoing antitrust battle between the Federal Trade Commission and the pharmaceutical industry over patent settlements in which brand-name manufacturers pay generic drug companies to delay entering the market.

Broadcasters including ABC, CBS, and NBC have brought a copyright infringement suit against Aereo, which plans to let its users watch live TV on their computers. The broadcasters, represented by Steven Fabrizio of Jenner & Block, hope to block Aereo before it launches on March 14.

Micron Technology and Hynix Semiconductor have fired back at Rambus Inc. in the appeal of their three-month price-fixing trial, arguing that two California judges properly excluded evidence of a co-conspirator's guilty plea agreement.

The government announced Thursday that Northrup would pay $325 million to settle a False Claims Act suit. But Northrup announced that the government would pay it $325 million to settle a long-running suit over a canceled cruise missile. So who's the winner? The FCA whistle-blower and his lawyers at Phillips & Cohen.

A month ago, when it went to trial against GlaxoSmithKline, several major pharmacy chains, and a class of drug wholesalers, Abbott Laboratories faced almost $10 billion in potential antitrust damages. On Wednesday, after five days of deliberation, the jury returned a verdict of just $3.5 million against Hurst's client.

Rambus's $240 million settlement with rival SK Hynix most likely leaves both sides a bit dissatisfied, but at least they can turn the page on a grinding court fight that's generated fees for several Am Law 200 firms.